Clinical Trial Detail

NCT ID NCT04221542
Title Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

prostate cancer

Therapies

AMG 509 + Dexamethasone

Age Groups: adult senior

No variant requirements are available.